Novozymes completes acquisition of MicroBioGen

Bitget2026/10/02 14:25

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Novozymes completed the acquisition of Australia-based MicroBioGen on Oct. 1, 2026, following receipt of required regulatory clearances.
Deal lifts Novozymes’ prior 23% stake to full ownership, extending a partnership and investment relationship that began in 2013.
MicroBioGen adds yeast-breeding and strain-development capabilities, with a track record in bioethanol and potential uses across other industrial markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novozymes A/S published the original content used to generate this news brief on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Novozymes completes acquisition of MicroBioGen

You may also like

Crypto prices